Papers by Jianmin Wu
4 results
- Research Square
Itaconate delays type 2 diabetes progression by alkylating RIPK3 to inhibit pancreatic β‑cell failure
Preprint: experiments in animalsInterventions - ADA Scientific Sessions 2026 Abstract
ASC37 Oral Tablets, GLP-1R/GIPR/GCGR Triple Agonist Peptide, Achieved Average Absolute Oral Bioavailability of 4.2% in Nonhuman Primate Studies
Experiments in animalsInterventions